Why is Medicalgorithmics SA ?
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -17.34
- The company has been able to generate a Return on Capital Employed (avg) of 0.27% signifying low profitability per unit of total capital (equity and debt)
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -35.80%, its profits have risen by 40.9%
- Along with generating -35.80% returns in the last 1 year, the stock has also underperformed Poland WIG in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Medicalgorithmics SA for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at PLN 6.26 MM
Highest at -10.55%
Highest at PLN 10.85 MM
Fallen by -1,382.26% (YoY
Highest at 5.95 times
Highest at PLN 0.01 MM
Highest at 0.12 %
Highest at PLN -0.15 MM
Highest at PLN 0.13 MM
Highest at PLN 0.01
At PLN 1.64 MM has Grown at 110.95%
Highest at 38.61 %
Lowest at PLN 5.03 MM
Here's what is working for Medicalgorithmics SA
Net Sales (PLN MM)
Operating Cash Flows (PLN MM)
Net Sales (PLN MM)
Operating Profit (PLN MM)
Operating Profit to Sales
Pre-Tax Profit (PLN MM)
Pre-Tax Profit (PLN MM)
Net Profit (PLN MM)
Net Profit (PLN MM)
EPS (PLN)
Inventory Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Medicalgorithmics SA
Interest Paid (PLN MM)
Debt-Equity Ratio
Cash and Cash Equivalents






